US Oncology Taking On Drug Distribution Role
Executive Summary
Cancer services company US Oncology is building its own drug distribution capacity to serve medical practices in its oncology network
You may also be interested in...
Part B Competitive Acquisition Plan Needs Significant Changes, Attorney Says
The Centers for Medicare & Medicaid Services' proposal for competitive acquisition of Part B-covered drugs requires "significant changes" to be effective, attorney Carolyn McElroy told an American Conference Institute/Pharmaceutical Care Management Association conference in Washington, D.C. April 18
U.S. Oncology To Go Private Ahead Of Medicare Part B Changes In 2005
U.S. Oncology plans to go private ahead of the 2005 reimbursement changes for chemotherapy drugs under the Medicare prescription drug law
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: